Rochester,NY 9/2/2009 9:51:27 PM
Myriad Genetics Inc. MYGN, To Present At The Morgan Stanley Global Healthcare Conference
Myriad Genetics Inc.
Myriad Genetics, Inc. announced that Peter D. Meldrum, President and CEO, is scheduled to present an overview of the Company at The Morgan Stanley Global Healthcare Conference, at 10:20 a.m. Eastern on September 14, 2009, at the Grand Hyatt Hotel in New York City.
About Myriad Genetics
Myriad Genetics, Inc. is a leading healthcare company focused on developing and marketing novel molecular diagnostic products. Myriad's news and other information are available on the Company's Web site at www.myriad.com.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
